3/18/20 16:52 | 3/16/20 | AMAG | Health | Drug | Pharmaceutical Preparations | Armistice Capital, LLC | NY | T | | P | 117 | 4.87 | 0 | 24 | 1 | 4,468 | I | | | | | | | | | | | | | | |
2/27/20 17:27 | 2/25/20 | AMAG | Health | Drug | Pharmaceutical Preparations | Armistice Capital, LLC | NY | T | | P | 298 | 8.29 | 0 | 36 | 1 | 4,444 | I | | | | | | | | | | | | | | |
1/28/20 16:48 | 1/24/20 | AMAG | Health | Drug | Pharmaceutical Preparations | Armistice Capital, LLC | NY | T | | P.m | 865 | 9.61 | 0 | 90 | 2 | 4,408 | M | | | | | | | | | | | | | | |
1/13/20 17:47 | 1/9/20 | AMAG | Health | Drug | Pharmaceutical Preparations | Armistice Capital, LLC | NY | T | | P.m | 363 | 11.92 | 0 | 30 | 0 | 8,396 | M | | | | | | | | | | | | | | |
8/9/19 17:05 | 8/7/19 | AMAG | Health | Drug | Pharmaceutical Preparations | Armistice Capital, LLC | NY | T | | P | 2,200 | 7.33 | 0 | 300 | 8 | 4,300 | M | | | | | | | | | | | | | | |
8/9/19 15:41 | 8/7/19 | AMAG | Health | Drug | Pharmaceutical Preparations | Camber Capital Management LP | MA | T | | P.m | 3,030 | 7.87 | 0 | 385 | 10 | 4,390 | I | | | | | | | | | | | | | | |
6/27/19 18:29 | 6/25/19 | AMAG | Health | Drug | Pharmaceutical Preparations | Armistice Capital, LLC | NY | T | | P.m | 4,416 | 8.87 | 0 | 498 | 14 | 4,000 | M | | | | | | | | | | | | | | |
5/29/19 16:27 | 5/28/19 | AMAG | Health | Drug | Pharmaceutical Preparations | Krop Julie | MA | O | Chief Me | P | 99 | 9.91 | 0 | 10 | 14 | 81 | D | | | | | | | | | | | | | | |
5/9/19 16:16 | 5/9/19 | AMAG | Health | Drug | Pharmaceutical Preparations | Heiden William K | MA | DO | P,CEO | P | 107 | 10.70 | 0 | 10 | 2 | 490 | D | | | | | | | | | | | | | | |
5/9/19 16:14 | 5/9/19 | AMAG | Health | Drug | Pharmaceutical Preparations | Bolgiano Elizabeth Scott | MA | O | CHRO | P | 55 | 10.93 | 0 | 5 | 7 | 75 | D | | | | | | | | | | | | | | |
11/10/15 16:18 | 11/10/15 | AMAG | Health | Drug | Pharmaceutical Preparations | Fallon John A. | MA | D | | P | 101 | 31.20 | 33 | 3 | 113 | 6 | D | 30 | -11 | -49 | -52 | -19 | -12 | -23 | 1 | -1 | -3 | -4 | -24 | -34 | -4 |
5/29/12 14:17 | 5/24/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Narachi Michael | MA | D | | P.m | 27 | 3.61 | 3 | 8 | New | 8 | D | -57 | -14 | -16 | -16 | -11 | -14 | 11 | 5 | 2 | -1 | 9 | 8 | 8 | 48 |
5/29/12 14:05 | 5/24/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Heiden William K | MA | DO | P,CEO | P.m | 0 | 0.00 | 3 | 10 | New | 10 | D | -57 | -14 | -16 | -16 | -11 | -14 | 11 | 5 | 2 | -1 | 9 | 8 | 8 | 48 |
5/29/12 13:53 | 5/24/12 | AMAG | Health | Drug | Pharmaceutical Preparations | De Silva Rajiv | MA | D | | P | 0 | 0.00 | 3 | 15 | New | 15 | D | -57 | -14 | -16 | -16 | -11 | -14 | 11 | 5 | 2 | -1 | 9 | 8 | 8 | 48 |
4/2/12 16:00 | 4/2/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | COO,Inte | P | 8 | 15.86 | 2 | 1 | 33 | 2 | D | -55 | -5 | 8 | -16 | -7 | -1 | 0 | -1 | 1 | -1 | -2 | -2 | 13 | 49 |
3/5/12 19:07 | 3/1/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Adage Capital Partners Gp LLC | MA | T | | P | 5,666 | 15.55 | 2 | 364 | 10 | 4,088 | I | -53 | -10 | 13 | -10 | -4 | 1 | 1 | -1 | 0 | 2 | -2 | -16 | -9 | 13 |
3/5/12 18:53 | 3/2/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Adage Capital Partners Gp LLC | MA | T | | P | 751 | 15.97 | 2 | 47 | 1 | 4,135 | I | -53 | -10 | 13 | -10 | -4 | 1 | 1 | -1 | 0 | 2 | -2 | -16 | -9 | 13 |
3/2/12 16:21 | 3/1/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | COO,Inte | P | 8 | 15.81 | 2 | 1 | 50 | 2 | D | -55 | -11 | 8 | -8 | -9 | -4 | -7 | -5 | 1 | 4 | 0 | -13 | -7 | 12 |
2/2/12 09:35 | 2/1/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | COO,Inte | P | 8 | 16.56 | 2 | 1 | 100 | 1 | D | -63 | -7 | 15 | 17 | -10 | -10 | 5 | -1 | 1 | 2 | -3 | -3 | -9 | -2 |
1/4/12 16:00 | 1/3/12 | AMAG | Health | Drug | Pharmaceutical Preparations | Thomas Frank E | MA | O | CFO,COO, | P.d | 10 | 19.10 | 3 | 1 | New | 1 | D | -51 | 4 | -1 | 35 | 13 | 1 | -2 | -1 | -2 | -6 | -11 | -15 | -17 | -13 |
12/2/11 17:10 | 11/30/11 | AMAG | Health | Drug | Pharmaceutical Preparations | Allen Lee F Md Phd | MA | O | Chief Me | P | 4 | 15.13 | 4 | 0 | 3 | 8 | D | -54 | 14 | -1 | 28 | 30 | 13 | 8 | 7 | 2 | 3 | 2 | -13 | -26 | -19 |
6/1/11 16:35 | 5/31/11 | AMAG | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | EVP,CFO, | P.a | 20 | 13.23 | 4 | 2 | 490 | 2 | D | -65 | -41 | 16 | 4 | 11 | 12 | 18 | 19 | 0 | -3 | 2 | -21 | -9 | -25 |
6/1/11 16:18 | 5/31/11 | AMAG | Health | Drug | Pharmaceutical Preparations | Allen Lee F Md Phd | MA | O | Chief Me | P | 17 | 13.23 | 4 | 1 | 68 | 3 | D | -65 | -41 | 16 | 4 | 11 | 12 | 18 | 19 | 0 | -3 | 2 | -21 | -9 | -25 |
6/1/11 16:01 | 5/31/11 | AMAG | Health | Drug | Pharmaceutical Preparations | Arkowitz David | MA | O | EVP,CFO, | P | 20 | 13.23 | 4 | 2 | 490 | 2 | D | -65 | -41 | 16 | 4 | 11 | 12 | 18 | 19 | 0 | -3 | 2 | -21 | -9 | -25 |
12/3/10 08:34 | 12/1/10 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Allen Lee F Md Phd | MA | O | Chief Me | P | 1 | 13.34 | 9 | 0 | 2 | 2 | D | -52 | -59 | -53 | -38 | -22 | 3 | 10 | -2 | 4 | 4 | 16 | 12 | 15 | 14 |
11/2/10 16:12 | 10/29/10 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adage Capital Partners Gp LLC | MA | T | | P.m | 15,871 | 15.87 | 13 | 1,000 | 18 | 6,498 | I | -46 | -58 | -53 | -50 | -20 | -22 | -20 | -20 | 5 | 2 | -3 | 11 | 11 | -12 |
6/1/10 16:19 | 5/28/10 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Allen Lee F Md Phd | MA | O | Chief Me | P | 17 | 27.06 | 11 | 1 | 17 | 4 | D | -20 | -39 | -17 | -7 | -12 | 1 | 0 | 2 | 7 | 4 | 13 | -16 | -54 | -45 |
6/1/10 16:00 | 5/28/10 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | EVP,CFO, | P | 18 | 27.06 | 11 | 1 | 54 | 2 | D | -20 | -39 | -17 | -7 | -12 | 1 | 0 | 2 | 7 | 4 | 13 | -16 | -54 | -45 |
12/2/09 16:24 | 12/1/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,Chie | P | 5 | 31.78 | 22 | 0 | 56 | 0 | D | -34 | 26 | -32 | -7 | 5 | -12 | -5 | -1 | -1 | 0 | -1 | -11 | -12 | -60 |
12/2/09 16:14 | 12/1/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Allen Lee F Md Phd | MA | O | Chief Me | P | 4 | 31.78 | 22 | 0 | 3 | 4 | D | -34 | 26 | -32 | -7 | 5 | -12 | -5 | -1 | -1 | 0 | -1 | -11 | -12 | -60 |
11/16/09 14:12 | 11/12/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adage Capital Partners Gp LLC | MA | T | | P.m | 4,300 | 43.00 | 27 | 100 | 2 | 5,351 | I | -29 | 14 | -20 | 0 | 6 | 24 | 5 | -2 | -1 | -6 | -12 | -10 | -25 | -65 |
11/13/09 16:00 | 6/2/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Allen Lee F Md Phd | MA | O | EVP,Chie | P | 16 | 25.61 | 27 | 1 | 21 | 4 | D | -27 | 136 | -19 | 0 | 5 | 21 | 3 | -1 | -1 | -6 | -14 | -11 | -20 | -64 |
11/12/09 16:46 | 6/2/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,Chie | P | 14 | 25.61 | 27 | 1 | | 0 | D | -26 | 110 | -19 | 0 | 4 | 19 | 10 | -2 | -2 | -8 | -14 | -11 | -25 | -65 |
11/10/09 18:56 | 11/6/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adage Capital Partners Gp LLC | MA | T | | P.dm | 10,419 | 44.15 | 27 | 236 | 5 | 5,112 | I | -28 | 76 | -20 | 0 | -3 | 22 | 14 | 8 | 1 | -3 | -10 | -15 | -21 | -63 |
11/5/09 20:07 | 11/3/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adage Capital Partners Gp LLC | MA | T | | P.m | 10,329 | 42.14 | 25 | 245 | 6 | 4,623 | I | -36 | 51 | -23 | -9 | -10 | 13 | 18 | 7 | 5 | 3 | -10 | -12 | -29 | -64 |
3/16/09 17:23 | 3/12/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adage Capital Partners Gp LLC | MA | T | | P | 279 | 25.32 | 12 | 11 | 1 | 2,143 | S | | | | | | | | | 10 | 11 | 35 | 77 | 33 | 17 |
3/11/09 18:26 | 3/9/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adage Capital Partners Gp LLC | MA | T | | P.m | 2,150 | 25.41 | 13 | 85 | 2 | 4,239 | S | | | | | | | | | 7 | 28 | 54 | 103 | 66 | 40 |
3/6/09 15:36 | 3/4/09 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Adage Capital Partners Gp LLC | MA | T | | P.d | 3,544 | 26.64 | 14 | 133 | 3 | 4,094 | S | | | | | | | | | 2 | 11 | 62 | 121 | 69 | 39 |
6/13/08 09:43 | 6/11/08 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,CBO, | P | 38 | 37.50 | 14 | 1 | 40 | 3 | D | 46 | -38 | -40 | 3 | -8 | -3 | -6 | 0 | 1 | 0 | -9 | 10 | -11 | 41 |
5/6/08 17:41 | 5/5/07 | AMAG | Health | Diagn | In Vitro & In Vivo Diagnostic | Arkowitz David | MA | O | CFO,Chie | P.d | 40 | 40.38 | 20 | 1 | 95 | 2 | D | 45 | -35 | -36 | -26 | 6 | 13 | 4 | -1 | -1 | 0 | -1 | 2 | -22 | 29 |
6/3/05 14:57 | 6/1/05 | AVM | Health | Diagn | In Vitro & In Vivo Diagnostic | Pereira Brian Jg | MA | D | | P.d | 0 | 0.00 | 0 | 16 | New | 16 | D | | | | | | | | | | | | | | |
11/8/04 17:45 | 10/14/04 | AVM | Health | Diagn | In Vitro & In Vivo Diagnostic | Bloch Sheldon L | MA | D | | P | 15 | 12.11 | 0 | 1 | New | 1 | I | | | | | | | | | | | | | | |
8/15/03 15:47 | 8/13/03 | AVM | Health | Diagn | In Vitro & In Vivo Diagnostic | Bvf Partners L P/il | IL | TH | Indirect | P | 190 | 8.78 | 0 | 22 | 2 | 1,438 | I | | | | | | | | | | | | | | |
7/29/03 17:28 | 7/25/03 | AVM | Health | Diagn | In Vitro & In Vivo Diagnostic | Bvf Partners L P/il | IL | TH | Indirect | P | 216 | 8.99 | 0 | 24 | 2 | 1,417 | I | | | | | | | | | | | | | | |